When Two Wrongs Make a Right
Statins Improve Outcomes of Rett Syndrome in Mice
By Anette Breindl
Tuesday, July 30, 2013
By applying an approach that is more commonly used in fruit flies and worms to mice, researchers have identified several new pathways that are disturbed in the autism spectrum disorder Rett syndrome. One of those pathways turned out to be cholesterol biosynthesis, and statins improved the symptoms of mice with Rett syndrome. The team identified the pathway through use of a so-called suppressor screen, a technique in which, essentially, two wrongs make a right.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.